FDA gives Denali accelerated approval for rare disease drugnews2026-03-25T19:24:58+00:00March 25th, 2026|Endpoints News|
FDA approves Corcept’s Lifyorli for ovarian cancer months earlynews2026-03-25T17:12:25+00:00March 25th, 2026|Endpoints News|
FDA warns ImmunityBio over misleading podcast with Patrick Soon-Shiongnews2026-03-24T15:10:14+00:00March 24th, 2026|Endpoints News|
FDA posts photos of Indian drugmaking facility cited in warning letternews2026-03-23T17:13:29+00:00March 23rd, 2026|Endpoints News|
FDA seeks input on Makary’s voucher pilotnews2026-03-20T17:56:56+00:00March 20th, 2026|Endpoints News|
Top HHS official tamps down expectations on scope of TrumpRxnews2026-03-20T16:45:24+00:00March 20th, 2026|Endpoints News|
Turmoil at ACIP continues after claim committee ‘disbanded’ is quickly refutednews2026-03-20T00:26:49+00:00March 20th, 2026|Endpoints News|
Novo wins FDA approval for high-dose Wegovy under commissioner’s vouchernews2026-03-19T18:06:03+00:00March 19th, 2026|Endpoints News|
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesitynews2026-03-19T11:51:29+00:00March 19th, 2026|Medical Device News Magazine|
